Literature DB >> 12695016

Stability of ranitidine in injectable solutions.

Midhat Vehabovic1, Sabira Hadzovic, Fatima Stambolic, Amina Hadzic, Elvedina Vranjes, Ediba Haracic.   

Abstract

Injectable solutions of ranitidine were prepared by dissolving ranitidine hydrochloride in water for injections. The following buffering system has been used: disodium phosphate (anhydrous), potassium dihydrogen phosphate, and phenol as a preservative. Inert gas (nitrogen) was used to displace oxygen from a solution and reduce the possibility of oxidative changes in the formulation. The solution was poured into 2-ml brown glass ampoules in asceptic condition. Ampoules samples have been stored at three different temperatures. They have been stored at 55 and 40 degrees C for 6 months, and at 25 degrees C for 12 months. TLC technique has been used for monitoring related substances, and HPLC technique for monitoring phenol and ranitidine content. It has been shown that only those samples that were stored at 25 degrees C were actually stable.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695016     DOI: 10.1016/s0378-5173(03)00067-x

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Physical Compatibility and Chemical Stability of Injectable and Oral Ranitidine Solutions.

Authors:  Kelly Fleming; Ronald F Donnelly
Journal:  Hosp Pharm       Date:  2018-03-07

2.  Effect of Formulation Factors and Oxygen Levels on the Stability of Aqueous Injectable Solution Containing Pemetrexed.

Authors:  Dong Han Won; Heejun Park; Eun-Sol Ha; Yong Min Kim; Hyung Don Hwang; Sun Woo Jang; Min-Soo Kim
Journal:  Pharmaceutics       Date:  2020-01-06       Impact factor: 6.321

Review 3.  N-nitrosodimethylamine (NDMA) contamination of ranitidine products: A review of recent findings.

Authors:  Fahad S Aldawsari; Yahya M Alshehry; Thamer S Alghamdi
Journal:  J Food Drug Anal       Date:  2021-03-15       Impact factor: 6.157

4.  Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.

Authors:  Ava Vila-Leahey; Sharon A Oldford; Paola A Marignani; Jun Wang; Ian D Haidl; Jean S Marshall
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.